European Medicines Agency finalises opinion on presence of nitrosamines in medicines

The European CHMP has issued an opinion requiring companies to take measures to limit the presence of nitrosamines in medicines as far as possible and to ensure levels of these impurities, which are classified as probable human carcinogens, do not exceed set limits.

Source:

European Medicines Agency